Gilead Sciences announced on Monday that it has set a price for Remdesivir, a drug that’s shown success in reducing the duration of some COVID-19 cases.
Gilead Sciences announced on Monday that it has set a price for Remdesivir, a drug that’s shown success in reducing the duration of some COVID-19 cases.
The California company that makes the COVID-19 drug Remdesivir announced Monday the price for the drug moving forward.
Shares in Britain's AstraZeneca opened lower on Monday after a report it had approached U.S. rival Gilead Sciences about a possible..